Califf Continues Clinical Trial Reform Crusade With Confirmation Vote Pending
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA Commissioner nominee outlines ideas for improving clinical trials in written responses to senators' questions; HELP Committee to vote Jan. 12.
You may also be interested in...
Woodcock's Legacy: CDER Organizational Improvements
In interview with the Pink Sheet, Center for Drug Evaluation and Research director discusses her 30-year career, retirement speculation, and upcoming projects.
PDUFA VI: FDA Proposes Expanding Sentinel, Real-World Safety Data Sources
Growth of post-market surveillance system also may require more resources.
Oral History Of Drug Development: FDA’s Califf Wants Woodcock, Temple To Share Their Stories
In an interview with “The Pink Sheet,” new deputy commissioner for medical products says FDA needs better ways of helping stakeholders, public understand agency thinking.